Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis.

Front Med (Lausanne) · 2020 · PMC7317305 · PMID 32637422

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although, patients who had been previously exposed to one anti-TNF had overall a better SEC survival compared to those exposed to ≥2 anti-TNFs, this did not reach statistical significance ( Figures 3A,B , respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.